Oral PTCTS (Particulated Transialidase) Removes Serum Microparticles and Decreases Inflammation in Atherosclerotic Plaques of Rabbits by Garavelo, Sherrira M.

Get full text
Get full text

Mice carrying 100P mutations show layer-specific decreases in proportions of PV+ cells. by Malgorzata Borkowska (3166719)

“…<p>(<b>A-D</b>) Decreases occurred in layer IV in fSSp, SSp, vAud and Vis, in layer V in SSp, vAud and Vis and in layer II/III in SSp. …”

DNA damage induces a pan-nuclear decrease in GFP-lamin A mobility. by Robert Mahen (409641)

Dark-rearing during the visual sensitive period decreases MeCP2 expression within the dLGN. by Yuki Yagasaki (402238)

F-actin decreases after M64HCl treatment in Caco-2 cells. by Sema Oncel (10152053)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

D452A, E464A, E470A, and E475A mutations decreased the calcium sensitivity. by Qinghuan Xiao (573411)

Treatment with a highly reducing agent decreases ubiquitination of D_4.2R WT and D_{4.2 4KR}R mutant. by Kamila Skieterska (841014)

Confocal images presenting the phenotypes of S100A6-immunopositive cells in the SVZ. by Katarzyna Bartkowska (453261)

Subjects:

Confocal images presenting the phenotypes of S100A6-immunopositive cells in the ARH. by Katarzyna Bartkowska (453261)

Subjects:

GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

Subjects:

Removal of the A-B linker did not decrease PIP₂ affinity. <i>A.-</i> by Paloma Aivar (124885)

siRNA-mediated knock-down significantly decreases MLL fusion expression levels. by Marieke H. van der Linden (706995)

S2 Data - by Dwight D. Harris (14484648)

“…Trichrome stain demonstrated a significant decrease in perivascular and interstitial fibrosis in the SIT group relative to CON (all p<0.05). …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Rho activation resulted in a growth cone collapse, but not decreased neurite lengths. by Frank Roloff (695802)

Treatment with FTY720 induces a decrease in inactive (phosphorylated) SAMHD1. by Rachel S. Resop (9238645)

Azurin induced a decrease sPcad levels and MMP2 activity. by Nuno Bernardes (435240)

“…<p>Treatments with azurin (100 µM) leads to decreased levels of the pro-invasive soluble form P- Cadherin in the conditioned media of cultured cells, as observed by Western Blot, for both MCF-7/AZ.Pcad (a) and SUM149 (b). …”

Supplementary Material for: Kidney and cardiovascular outcomes in older population with mildly to moderately decreased kidney function - A nationwide cohort study by Jeon J. (10323467)

“…Introduction: Although the prevalence of chronic kidney disease (CKD) is increasing in the aging population, the clinical relevance of the CKD definition (glomerular filtration rate [GFR] < 60 ml/min/1.73 m2) in older populations remains debatable. We investigated the clinical outcomes in older populations with mildly to moderately decreased GFR (45–59 ml/min/1.73 m2, CKD stage 3A). …”

Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

“…(<b>C</b>) There were no corresponding changes in the proportions of GAD67+ cells. (<b>D</b>, <b>E</b>) No major change was observed in the proportion of cells expressing calretinin (CLR) or somatostatin (STT) across the mutant cortex (n = 3–8 animals for each comparison; data are means ± sems; * p<0.05, ** p<0.01, two-way ANOVA with Dunnet’s multiple comparisons test where applicable). …”